Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Synthetic HIV V3 Glycopeptide Immunogen Carrying a N334 N-Glycan Induces Glycan-Dependent Antibodies with Promiscuous Site Recognition.
Journal: Journal of medicinal chemistry
Published: November 03, 2018
Revisiting the substrate specificity of mammalian α1,6-fucosyltransferase reveals that it catalyzes core fucosylation of N-glycans lacking α1,3-arm GlcNAc.
Journal: The Journal of biological chemistry
Published: June 23, 2017
Synthetic multivalent V3 glycopeptides display enhanced recognition by glycan-dependent HIV-1 broadly neutralizing antibodies.
Journal: Chemical communications (Cambridge, England)
Published: May 04, 2017
Synthetic Three-Component HIV-1 V3 Glycopeptide Immunogens Induce Glycan-Dependent Antibody Responses.
Journal: Cell chemical biology
Published: April 21, 2017
Systematic Synthesis and Binding Study of HIV V3 Glycopeptides Reveal the Fine Epitopes of Several Broadly Neutralizing Antibodies.
Journal: ACS chemical biology
Published: April 18, 2017
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller.
Journal: Science translational medicine
Published: July 22, 2016
Showing 1-7 of 7
Last Updated: 09/26/2026